{"entity":{"type":"insider","cik":"0001542836","url":"/insider/0001542836","json_url":"/insider/0001542836.json","name":"Regals Fund LP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":7,"first":"2012-06-27","last":"2014-06-10","span_basis":"filed_date"},"name_variants":[{"name":"Regals Fund LP","source":"filing","n_filings":7,"first_seen":"2012-06-27","last_seen":"2014-06-10"}],"transactions":[{"id":6772093,"accession":"0001140361-14-024984","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-14-024984","line_url":"/filing/0001140361-14-024984#line-1","is_derivative":false,"issuer_cik":"0001176309","issuer_name":"ORAMED PHARMACEUTICALS INC.","issuer_ticker":"ORMP","issuer_name_source":null,"issuer_url":"/issuer/0001176309","owner_cik":null,"owner_name":"Slager David Mark; Regals Fund LP; REGALS CAPITAL MANAGEMENT LP","owner_display_name":"Slager David Mark","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2252.0,"shares_display":"2,252","price_per_share":4.44,"price_display":"4.44","price_state":"stated","total_value":9998.88,"total_display":"9,998.88","total_whole":"9,999","shares_owned_after":1453637.0,"shares_owned_after_display":"1,453,637","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-06-06","filed_date":"2014-06-10","scope":"insider"},{"id":6738516,"accession":"0001140361-14-014133","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-14-014133","line_url":"/filing/0001140361-14-014133#line-2","is_derivative":false,"issuer_cik":"0001176309","issuer_name":"ORAMED PHARMACEUTICALS INC.","issuer_ticker":"ORMP","issuer_name_source":null,"issuer_url":"/issuer/0001176309","owner_cik":null,"owner_name":"Slager David Mark; Regals Fund LP; REGALS CAPITAL MANAGEMENT LP","owner_display_name":"Slager David Mark","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":47300.0,"shares_display":"47,300","price_per_share":10.8996,"price_display":"10.90","price_state":"stated","total_value":515551.08,"total_display":"515,551.08","total_whole":"515,551","shares_owned_after":1451385.0,"shares_owned_after_display":"1,451,385","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-03-25","filed_date":"2014-03-25","scope":"insider"},{"id":6738513,"accession":"0001140361-14-014133","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-14-014133","line_url":"/filing/0001140361-14-014133#line-1","is_derivative":false,"issuer_cik":"0001176309","issuer_name":"ORAMED PHARMACEUTICALS INC.","issuer_ticker":"ORMP","issuer_name_source":null,"issuer_url":"/issuer/0001176309","owner_cik":null,"owner_name":"Slager David Mark; Regals Fund LP; REGALS CAPITAL MANAGEMENT LP","owner_display_name":"Slager David Mark","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":27700.0,"shares_display":"27,700","price_per_share":10.1537,"price_display":"10.15","price_state":"stated","total_value":281257.49,"total_display":"281,257.49","total_whole":"281,257","shares_owned_after":1404085.0,"shares_owned_after_display":"1,404,085","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-03-24","filed_date":"2014-03-25","scope":"insider"},{"id":6634791,"accession":"0001140361-14-005083","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-14-005083","line_url":"/filing/0001140361-14-005083#line-2","is_derivative":false,"issuer_cik":"0001176309","issuer_name":"ORAMED PHARMACEUTICALS INC.","issuer_ticker":"ORMP","issuer_name_source":null,"issuer_url":"/issuer/0001176309","owner_cik":null,"owner_name":"REGALS CAPITAL MANAGEMENT LP; Slager David Mark; Regals Fund LP","owner_display_name":"REGALS CAPITAL MANAGEMENT LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":26800.0,"shares_display":"26,800","price_per_share":14.9605,"price_display":"14.96","price_state":"stated","total_value":400941.4,"total_display":"400,941.40","total_whole":"400,941","shares_owned_after":1376385.0,"shares_owned_after_display":"1,376,385","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-02-06","filed_date":"2014-02-06","scope":"insider"},{"id":6634787,"accession":"0001140361-14-005083","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-14-005083","line_url":"/filing/0001140361-14-005083#line-1","is_derivative":false,"issuer_cik":"0001176309","issuer_name":"ORAMED PHARMACEUTICALS INC.","issuer_ticker":"ORMP","issuer_name_source":null,"issuer_url":"/issuer/0001176309","owner_cik":null,"owner_name":"REGALS CAPITAL MANAGEMENT LP; Slager David Mark; Regals Fund LP","owner_display_name":"REGALS CAPITAL MANAGEMENT LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":24492.0,"shares_display":"24,492","price_per_share":16.3236,"price_display":"16.32","price_state":"stated","total_value":399797.6112,"total_display":"399,797.61","total_whole":"399,798","shares_owned_after":1349585.0,"shares_owned_after_display":"1,349,585","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-02-05","filed_date":"2014-02-06","scope":"insider"},{"id":5501853,"accession":"0001140361-13-028008","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-13-028008","line_url":"/filing/0001140361-13-028008#line-3","is_derivative":false,"issuer_cik":"0001176309","issuer_name":"ORAMED PHARMACEUTICALS INC.","issuer_ticker":"ORMP","issuer_name_source":null,"issuer_url":"/issuer/0001176309","owner_cik":null,"owner_name":"Slager David Mark; REGALS CAPITAL MANAGEMENT LP; Regals Fund LP","owner_display_name":"Slager David Mark","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6630.0,"shares_display":"6,630","price_per_share":7.3958,"price_display":"7.40","price_state":"stated","total_value":49034.154,"total_display":"49,034.15","total_whole":"49,034","shares_owned_after":1325093.0,"shares_owned_after_display":"1,325,093","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-07-10","filed_date":"2013-07-12","scope":"insider"},{"id":3074419,"accession":"0001140361-12-045904","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-12-045904","line_url":"/filing/0001140361-12-045904#line-1","is_derivative":false,"issuer_cik":"0001176309","issuer_name":"ORAMED PHARMACEUTICALS INC.","issuer_ticker":"ORMP","issuer_name_source":null,"issuer_url":"/issuer/0001176309","owner_cik":null,"owner_name":"REGALS CAPITAL MANAGEMENT LP; Slager David Mark; Regals Fund LP","owner_display_name":"REGALS CAPITAL MANAGEMENT LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":405405.0,"shares_display":"405,405","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":9127670.0,"shares_owned_after_display":"9,127,670","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-11-02","filed_date":"2012-11-06","scope":"insider"},{"id":2293106,"accession":"0001140361-12-035793","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-12-035793","line_url":"/filing/0001140361-12-035793#line-1","is_derivative":false,"issuer_cik":"0001132143","issuer_name":"LEGEND INTERNATIONAL HOLDINGS INC","issuer_ticker":"LGDI","issuer_name_source":null,"issuer_url":"/issuer/0001132143","owner_cik":null,"owner_name":"Slager David Mark; REGALS CAPITAL MANAGEMENT LP; Regals Fund LP","owner_display_name":"Slager David Mark","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":23431180.0,"shares_display":"23,431,180","price_per_share":0.07,"price_display":"0.07","price_state":"stated","total_value":1640182.6,"total_display":"1,640,182.60","total_whole":"1,640,183","shares_owned_after":70345195.0,"shares_owned_after_display":"70,345,195","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-08-07","filed_date":"2012-08-08","scope":"insider"},{"id":2404369,"accession":"0001140361-12-031344","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-12-031344","line_url":"/filing/0001140361-12-031344#line-1","is_derivative":false,"issuer_cik":"0001132143","issuer_name":"LEGEND INTERNATIONAL HOLDINGS INC","issuer_ticker":"LGDI","issuer_name_source":null,"issuer_url":"/issuer/0001132143","owner_cik":null,"owner_name":"Slager David Mark; Regals Fund LP; REGALS CAPITAL MANAGEMENT LP","owner_display_name":"Slager David Mark","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":22640725.0,"shares_display":"22,640,725","price_per_share":0.1,"price_display":"0.10","price_state":"stated","total_value":2264072.5,"total_display":"2,264,072.50","total_whole":"2,264,073","shares_owned_after":46914015.0,"shares_owned_after_display":"46,914,015","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-06-25","filed_date":"2012-06-27","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001176309","name":"ORAMED PHARMACEUTICALS INC.","url":"/issuer/0001176309","role":"Ten percent owner","n_filings":5,"first_seen":"2012-11-06","last_seen":"2014-06-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001132143","name":"LEGEND INTERNATIONAL HOLDINGS INC","url":"/issuer/0001132143","role":"Ten percent owner","n_filings":2,"first_seen":"2012-06-27","last_seen":"2012-08-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001542836","retrieved_at":"2026-08-25T14:34:41+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}